Retaglutide is a novel GLP-1 receptor agonist currently under research for the management of type 2 diabetes. This medication works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://maepdio086565.is-blog.com/45824411/trelaglutide-exploring-a-new-option-for-chronic-diseases